Digital Biomarkers Market, By Type (Physiological, Behavioral, and Cognitive), By Application, By End-Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
REPORT HIGHLIGHT
Digital Biomarkers Market size was valued at US$ 3,540.54 Million in 2024, expanding at a CAGR of 22.90% from 2025 to 2032.
Digital biomarkers are measurable indicators of biological processes, conditions, or diseases that are captured and monitored using digital technologies such as wearables, mobile apps, and remote monitoring devices. These biomarkers provide real-time, continuous, and objective data regarding an individual’s health status. Unlike traditional biomarkers, which are typically obtained from blood samples or clinical tests, digital biomarkers offer a dynamic and non-invasive method for tracking health.
The growing demand for personalized healthcare and early disease detection is driving the need for digital biomarkers. Traditional clinical visits are often infrequent, leading to gaps in understanding a patient’s health condition. Digital biomarkers help bridge this gap by enabling continuous monitoring, allowing health issues to be detected before they manifest as severe symptoms. This timely detection enables earlier interventions, ultimately improving patient outcomes.
The significance of digital biomarkers lies in their potential to revolutionize healthcare. They provide accurate, real-time insights into a person’s health, facilitating personalized treatment plans and monitoring of chronic conditions like diabetes, cardiovascular diseases, and neurological disorders. Digital biomarkers also enhance the effectiveness of clinical trials, providing richer data to assess drug efficacy and safety. Additionally, they play a crucial role in promoting preventive care, as they allow for the tracking of early signs of diseases and support proactive health management.
Digital Biomarkers Market- Market Dynamics
Growing Focus on Remote Patient Monitoring Driving Digital Biomarkers Market Growth
The increasing emphasis on remote patient monitoring (RPM) is a key factor driving the growth of the Digital Biomarkers market. RPM leverages digital technologies such as wearables, mobile applications, and sensors to monitor patients\' health outside of traditional clinical settings. As healthcare shifts toward more patient-centric care models and the prevalence of chronic diseases rises, RPM allows healthcare providers to track patient health in real time, enabling timely interventions and better management of conditions like diabetes, hypertension, and cardiovascular diseases.
A major driver behind the adoption of RPM is the increasing demand for personalized and continuous healthcare. Digital biomarkers provide continuous, real-time data, facilitating more tailored treatments and enhancing patient outcomes. According to the U.S. Department of Health and Human Services, RPM has been shown to reduce hospital readmission rates by 25% and lower healthcare costs by decreasing the need for in-person visits. This highlights RPM\'s effectiveness in improving patient care while optimizing healthcare resource utilization.
The COVID-19 pandemic has further accelerated the demand for remote monitoring, as both patients and healthcare providers seek safer alternatives to in-person visits. Additionally, the increasing prevalence of chronic diseases, along with technological advancements in wearable devices, is fueling the market for digital biomarkers, significantly transforming the future of healthcare.
Digital Biomarkers Market- Segmentation Analysis:
The Global Digital Biomarkers Market is segmented on the basis of Type, Application, End-Use and Region.
The Digital Biomarkers market is segmented into three categories based on Type: Physiological, Behavioral, and Cognitive. Physiological biomarkers lead the market due to their ability to provide real-time, accurate insights into vital signs such as heart rate, blood pressure, and temperature—key indicators for monitoring chronic conditions. These biomarkers are extensively used in wearable devices and remote monitoring solutions, making them a critical component of personalized healthcare.
The market is also divided by End-Use into three categories: Healthcare Providers, Pharmaceutical Companies, and Research Organizations. Healthcare providers dominate the market, as they play a crucial role in utilizing digital biomarkers for patient monitoring, diagnosis, and treatment optimization. Their adoption of these technologies enhances patient care by enabling real-time data tracking, early disease detection, and the creation of personalized treatment plans, thus driving market growth.
Digital Health Market Growth: The global digital health market is projected to reach $536.6 billion by 2025, reflecting significant growth in digital health technologies, including digital biomarkers.
Biopharma Industry Investment: In 2021, the biopharma industry tripled its R&D spending to nearly $1 billion, indicating a strong commitment to innovation in healthcare technologies.
Digital Health Post-COVID-19: The COVID-19 pandemic has accelerated the adoption of digital health solutions, with increased investments in digital health technologies to enhance healthcare delivery and patient monitoring.
Digital Biomarkers Market- Geographical Insights
The Digital Biomarkers market exhibits significant geographical variation, with North America leading the market due to its advanced healthcare infrastructure, widespread adoption of wearable technologies, and growing government support for digital health initiatives. The U.S. is at the forefront, driven by a high prevalence of chronic diseases, advancements in telemedicine, and substantial investments in healthcare innovation. Additionally, U.S. policies, such as the 21st Century Cures Act, actively promote the use of digital health tools, further accelerating the adoption of digital biomarkers.
Europe follows closely, with increasing emphasis on patient-centered healthcare and remote patient monitoring. Countries like Germany and the UK are increasingly integrating digital biomarkers into clinical practice, with a focus on enhancing personalized medicine and improving chronic disease management.
In the Asia-Pacific region, the market is expanding rapidly due to rising healthcare spending, growing awareness of chronic disease management, and ongoing technological advancements. Countries like Japan, China, and India are increasingly adopting digital health solutions to address the rising burden of diseases and improve healthcare access.
The Middle East and Africa (MEA) are also experiencing growth, though at a slower pace. Digital health adoption in these regions is still in its early stages, but government-backed initiatives and improving healthcare systems are gaining momentum and driving the adoption of digital biomarkers.
Digital Biomarkers Market- Competitive Landscape:
The Digital Biomarkers market is characterized by a diverse range of players, including technology companies, healthcare providers, and research organizations. Companies in this space are focusing on innovation and strategic partnerships to expand their product offerings. Many key players are collaborating with healthcare institutions to integrate digital biomarkers into clinical workflows, enhancing their effectiveness in patient monitoring and disease management.
In addition, there is a growing trend of mergers and acquisitions as companies aim to strengthen their market positions and enhance their technological capabilities. Firms are also investing in product development, incorporating advanced AI algorithms, machine learning, and data analytics to improve the accuracy and predictive capabilities of digital biomarkers. The market remains highly fragmented, with competitors focusing on technological innovation, ease of integration, regulatory compliance, and cost-effectiveness to differentiate themselves.
As personalized healthcare becomes increasingly important, digital biomarkers are emerging as crucial tools for managing chronic conditions, which is driving the demand for innovative solutions. Additionally, the market is seeing a rise in startups, particularly driven by advancements in wearable devices, mobile applications, and sensor technologies, challenging traditional players to adapt to the rapidly evolving healthcare landscape.
Recent Developments
February 2024: Biofourmis secured four new agreements with leading pharmaceutical companies, expanding its role in digital clinical trials and the development of digital biomarkers, particularly in the field of oncology. The company\'s expertise in digital biomarkers and decentralized clinical trials is helping to reduce study timelines and improve participant engagement through remote monitoring and in-home services.
November 2024: Neuron23 partnered with Roche to use its digital biomarker and device as a primary endpoint in the Phase 2 NEULARK clinical trial for Parkinson\'s disease. By utilizing Roche\'s navify digital biomarker solution, the collaboration aims to enhance precision, reduce patient burden, and improve clinical trial efficiency through continuous, objective symptom tracking, compared to traditional clinical rating scales.
December 2024: Koneksa introduced a new data syndication model to enhance drug discovery by utilizing digital health data for clinical and translational science. This model fosters collaboration among stakeholders, such as biopharmaceutical companies, enabling faster study launches and real-time data sharing. The LEARNS study, which is evaluating Parkinson\'s disease progression using wearable devices and digital health tools, exemplifies this approach to accelerate the validation of digital biomarkers in clinical trials.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIGITAL BIOMARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Biofourmis, Inc.
Roche Holding AG
Koneksa Health, Inc.
Philips Healthcare
Abbott Laboratories
Google LLC
Biogen, Inc.
Garmin Ltd.
Apple Inc.
Medtronic PLC
Chrono Therapeutics, Inc.
Senseonics Holdings, Inc.
Proteus Digital Health, Inc.
Omron Healthcare Co., Ltd.
ActiGraph, LLC
Others
GLOBAL DIGITAL BIOMARKERS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
Physiological
Behavioral
Cognitive
Others
GLOBAL DIGITAL BIOMARKERS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
Wearable Devices
Mobile Applications
Remote Monitoring Systems
Sensor Technologies
Others
GLOBAL DIGITAL BIOMARKERS MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032
Healthcare Providers
Pharmaceutical Companies
Research Organizations
Others
GLOBAL DIGITAL BIOMARKERS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- Uk
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest Of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest Of Apac
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest Of Latam
The Middle East And Africa
- Saudi Arabia
- Uae
- Israel
- Turkey
- Algeria
- Egypt
- Rest Of Mea
TABLE OF CONTENT
1. Digital Biomarkers Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Digital Biomarkers Market Snippet by Type
2.1.2. Digital Biomarkers Market Snippet by Application
2.1.3. Digital Biomarkers Market Snippet by End-Use
2.1.4. Digital Biomarkers Market Snippet by Country
2.1.5. Digital Biomarkers Market Snippet by Region
2.2. Competitive Insights
3. Digital Biomarkers Key Market Trends
3.1. Digital Biomarkers Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Digital Biomarkers Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Digital Biomarkers Market Opportunities
3.4. Digital Biomarkers Market Future Trends
4. Digital Biomarkers Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Digital Biomarkers Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Digital Biomarkers Market Landscape
6.1. Digital Biomarkers Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Digital Biomarkers Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
7.1.2. Physiological
7.1.3. Behavioral
7.1.4. Cognitive
7.1.5. Others
8. Digital Biomarkers Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Wearable Devices
8.1.3. Mobile Applications
8.1.4. Remote Monitoring Systems
8.1.5. Sensor Technologies
8.1.6. Others
9. Digital Biomarkers Market – By End-Use
9.1. Overview
9.1.1. Segment Share Analysis, By End-Use, 2024 & 2032 (%)
9.1.2. Healthcare Providers
9.1.3. Pharmaceutical Companies
9.1.4. Research Organizations
9.1.5. Others
10. Digital Biomarkers Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Digital Biomarkers Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Digital Biomarkers Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Digital Biomarkers Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Digital Biomarkers Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Digital Biomarkers Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Digital Biomarkers Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Biofourmis, Inc.
11.2.2. Roche Holding AG
11.2.3. Koneksa Health, Inc.
11.2.4. Philips Healthcare
11.2.5. Abbott Laboratories
11.2.6. Google LLC
11.2.7. Biogen, Inc.
11.2.8. Garmin Ltd.
11.2.9. Apple Inc.
11.2.10. Medtronic PLC
11.2.11. Chrono Therapeutics, Inc.
11.2.12. Senseonics Holdings, Inc.
11.2.13. Proteus Digital Health, Inc.
11.2.14. Omron Healthcare Co., Ltd.
11.2.15. ActiGraph, LLC
11.2.16. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
